Sloan-Kettering Cancer Center Memorial, 10% Owner at Actinium Pharmaceuticals, Inc. (ATNM), sold 36,400 shares at $1.91 ($69K) on 2016-05-25, disclosed to the SEC on 2016-05-26.
Open-market sale of $69k ATNM by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.90 | 400 | $760 | 1.1% |
| 2 | $1.90 | 26,000 | $49K | 71.3% |
| 3 | $1.91 | 4,600 | $9K | 12.7% |
| 4 | $1.91 | 5,300 | $10K | 14.6% |
| 5 | $1.92 | 100 | $192 | 0.3% |
| Total | $1.90 avg | 36,400 |
| $69K |
| 100% |
| Filing → |
| ATNM | SELL | 2016-08-17 | $17K | — | Filing → |
| ATNM | SELL | 2016-07-14 | $6K | — | Filing → |
| ATNM | SELL | 2016-07-12 | $40K | — | Filing → |